← Open Payments lookup

MELISSA GARCIA: Open Payments

NPI 1609487222 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,522 in 77 payments from 29 companies in 2025. Trend: 2023 $4,715 · 2024 $3,362 · 2025 $1,522

Food & beverage: $1,522
CompanyPaymentsAmount
ABBVIE INC.21$297
GlaxoSmithKline, LLC.6$122
Otsuka America Pharmaceutical, Inc.5$104
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$100
Inspire Medical Systems, Inc.1$99
AstraZeneca Pharmaceuticals LP4$70
VERTEX PHARMACEUTICALS INCORPORATED3$61
SCILEX PHARMACEUTICALS INC.3$58
Boehringer Ingelheim Pharmaceuticals, Inc.2$54
Amgen Inc.3$52

Products named: VRAYLAR, LINZESS, REXULTI, RELISTOR, INSPIRE, TRELEGY ELLIPTA, JARDIANCE, JOURNAVX.

Industry payments across TX — which companies pay providers there.